4.2 Article

Atrazine and cancer: a review of the epidemiologic evidence

Journal

EUROPEAN JOURNAL OF CANCER PREVENTION
Volume 22, Issue 2, Pages 169-180

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/CEJ.0b013e32835849ca

Keywords

atrazine; cancer; epidemiology; hazard identification

Categories

Funding

  1. Syngenta Crop Protection, LLC

Ask authors/readers for more resources

The aim of this study was to evaluate the conflicting reports from the Environmental Protection Agency and the Scientific Advisory Panel (Panel) on the carcinogenicity of atrazine in order to determine whether the results from epidemiologic studies support a causal relationship between atrazine and any specific cancer. We reviewed the Environmental Protection Agency and Panel reports in the context of all the epidemiologic studies on the specific cancers of interest. A weight-of-evidence approach leads to the conclusion that there is no causal association between atrazine and cancer and that occasional positive results can be attributed to bias or chance. Atrazine appears to be a good candidate for a category of herbicides with a probable absence of cancer risk. Atrazine should be treated for regulatory and public health purposes as an agent unlikely to pose a cancer risk to humans. European Journal of Cancer Prevention 22:169-180 (c) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available